MADISON AVENUE PARTNERS LP
Q3 2022 Form 13-F

NEW YORK, NEW YORK
CIK 0001801265 · CRD 298610 · SEC-registered investment adviser
$466.1M Reported Value Total

MADISON AVENUE PARTNERS LP reports 3 total accounts under management (AUM). There are 3 discretionary accounts valued at $1,604,741,217, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
1 fund · $3.9B gross asset value
Hedge Fund: $3.9B
Source: Form ADV filed 2026-03-02
Reported value
$466.1M
Quarter over quarter
+3.9%
Holdings
18
Top-10 concentration
95.1%

Key People

Form ADV owners & control persons
Eli Jackson Samaha
MANAGING PARTNER
Christopher Adien Carroll
CFO / CCO

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2022 13F record

Q3 2022 13F filing summary

Q3 2022 Form 13F portfolio summary
Period of report September 30, 2022
Filed November 14, 2022
Form 13F-HR
Reported value $466.1M
Positions 18
Change in reported value -4.6%
New positions 6
Exited positions 4
Position turnover 45.5%
Top-10 concentration 95.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q2 2026 13F
Filed Aug 14, 2026
25 $2.3B
Q1 2026 13F
Filed May 15, 2026
27 $2.3B
Q4 2025 13F
Filed Feb 17, 2026
23 $2.3B
Q3 2025 13F
Filed Nov 14, 2025
20 $1.7B
Q2 2025 13F
Filed Aug 14, 2025
26 $1.5B
Q1 2025 13F
Filed May 15, 2025
22 $1.2B
Q4 2024 13F
Filed Feb 14, 2025
15 $944.4M
Q3 2024 13F
Filed Nov 14, 2024
25 $1.1B
Q2 2024 13F
Filed Aug 14, 2024
20 $791.6M
Q1 2024 13F
Filed May 15, 2024
18 $619.9M
Q4 2023 13F
Filed Feb 16, 2024
19 $708.3M
Q3 2023 13F
Filed Nov 14, 2023
20 $704.7M
Q2 2023 13F
Filed Aug 14, 2023
19 $458.3M
Q1 2023 13F
Filed May 15, 2023
18 $464.9M
Q4 2022 13F
Filed Feb 14, 2023
22 $564.5M
Q3 2022 13F
Filed Nov 14, 2022
18 $466.1M
Q2 2022 13F
Filed Aug 15, 2022
16 $488.8M
Q1 2022 13F
Filed May 16, 2022
18 $535.6M
Q4 2021 13F
Filed Feb 14, 2022
16 $461.9M
Q3 2021 13F
Filed Nov 15, 2021
17 $451.3M

7 earlier quarters on file — choose one from the quarter menu above.

Top 18 holdings · Q3 2022

Largest Q3 2022 13F positions by reported value
# Holding Reported value % of portfolio
1 GHC GRAHAM HLDGS CO $112.3M 24.09%
2 TBPH THERAVANCE BIOPHARMA INC $71.1M 15.25%
3 SLVM SYLVAMO CORP $65.3M 14.0%
4 SMCI SUPER MICRO COMPUTER INC $50.4M 10.81%
5 STGW STAGWELL INC $44.5M 9.54%
6 TRQ TURQUOISE HILL RES LTD $31.7M 6.8%
7 PFSW PFSWEB INC $24.5M 5.26%
8 TSVT 2SEVENTY BIO INC $17.5M 3.75%
9 GOSS GOSSAMER BIO INC $16.6M 3.56%
10 JRVR JAMES RIV GROUP LTD $9.5M 2.04%
11 SPB SPECTRUM BRANDS HLDGS INC NE $4.3M 0.91%
12 FSP FRANKLIN STR PPTYS CORP $3.8M 0.82%
13 TK TEEKAY CORPORATION $3.7M 0.8%
14 LNSR LENSAR INC $3.7M 0.8%
15 OVID OVID THERAPEUTICS INC $2.6M 0.55%
16 AIV APARTMENT INVT & MGMT CO $2.2M 0.48%
17 SFEXXXX SAFEGUARD SCIENTIFICS INC $1.7M 0.37%
18 ONL ORION GROUP HLDGS INC $713.0K 0.15%

Values as reported on the Q3 2022 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings